Tinnitus: Present and future

Current Opinion in Otolaryngology and Head and Neck Surgery

Volumn 9, Issue 5, 2001, Pages 323-328

  Sahley, Tony L ^a   Nodar, Richard H ^a  

^a CLEVELAND STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CENTRAL NERVOUS SYSTEM; DISEASE ASSOCIATION; EVOKED AUDITORY RESPONSE; HUMAN; NERVE CELL; NEUROPHYSIOLOGY; PERCEPTION DEAFNESS; PERIPHERAL NERVOUS SYSTEM; PRIORITY JOURNAL; REVIEW; SOUND; STIMULUS RESPONSE; STRESS; TINNITUS; TREATMENT PLANNING;

EID: 0034807519     PISSN: 10689508     EISSN: None     Source Type: Journal    
DOI: 10.1097/00020840-200110000-00013     Document Type: Review

References (92)

1. Medical aspects of tinnitus
2. Introduction
3. Tinnitus retraining therapy (TRT) as a method for treatment of tinnitus and hyperacusis patients
4. Drug treatments for tinnitus: The Tulane experience
5. A systematic classification of tinnitus generator mechanisms
6. Pulsitile tinnitus
7. Pulsitile tinnitus
8. 'CAPPE'-a strategy for counseling tinnitus patients
9. Antidepressant drugs and tinnitus
10. Treatment of tinnitus based on a neurophysiological model
11. Psychological treatments for tinnitus
12. Anxiety and depression in tinnitus sufferers
13. Tinnitus and depression
14. Psychological distress in patients with tinnitus
15. Treatment for hyperacusis
16. Processing of the tinnitus signal within the brain
17. Noise, aminoglycosides, and diuretuics
18. Increased susceptibility of male rats to kanamycin-induced cochleotoxicity
19. Mechanisms of salicylate ototoxicity
20. Tinnitus and neural activity
21. Single neuron labeling and chronic cochlear pathology II. Stereocilia damage and alterations of spontaneous discharge rates
22. Single neuron labeling and chronic cochlear pathology III. Stereocilia damage and alterations of threshold tuning curves
23. Brownian motion in the cochlear partition
24. Outer hair cell electromotility and otoacoustie emissions
25. Effect of noise on auditory nerve responses
26. On the pathophysiology of tinnitus: A review and a peripheral model
27. Clinical reviews: Neural mechanisms of tinnitus
28. Neural mechanisms of tinnitus: The pathological ensemble spontaneous activity of the auditory system
29. Changes in spontaneous neural activity in the dorsal cochfear nucleus following exposure to intense sound: Relation to threshold shift
30. Neurophysiologic mechanisms of tinnitus
31. Developing an objective measurement tool for evaluating tinnitus: Spectral averaging
32. Auditory-nerve spontaneous rates vary predictably with threshold
33. Spectral analysis of brain activity in the study of tinnitus
34. Alterations in average spectrum of cochleoneural activity by long-term saficylate treatment in the guinea pig: A plausible index of tinnitus
35. A physiological animal model of peripheral tinnitus
36. Asynchronous neural activity recorded from the round window
37. Effects of kainic acid on the cochlear potentials and distortion product otoacoustic emissions in chinchilla
38. Concentration-response relationships for salicylate-induced ototoxicity in normal volunteers
39. Analgesic-antipyretic and antiinflammatory agents and drugs employed in the treatment of gout
40. Animal models of tinnitus
41. Ototoxic effects of salicylates on the responses of single cochlear nerve fibres and on cochlear potentials
42. Salicylate-induced changes in spontaneous activity of single units in the inferior colliculus of the guinea pig
43. Recent findings from an animal model of tinnitus
44. Management of tinnitus aurium with lidocaine and carbamazepine
45. Modulation of synaptic efficacy as a basis for tinnitis: Hints suggested from the effects of quinine and aspirin on cochlear neurotransmission
46. N-methyl-d-aspartate-induced oscillations in excitatory afferent neurotransmission in the guinea pig cochlea
47. Endogenous dynorphins: Possible role in peripheral tinnitus
48. A biochemical model of peripheral tinnitus
49. The analogy between tinnitus and pain
50. Similarities between chronic pain and tinnitus
51. Similarities between severe tinnitus and chronic pain
52. Physiological properties of unmyelinated fiber projections to the spinal cord
53. Evidence for a central component of postinjury pain hypersensitivity
54. Cannabinoid WIN 55,212-2 inhibits the activity-dependent facilitation of spinal nociceptfve responses
55. Contribution of central neuroplasticity to pathological pain: Review of clinical and experimental evidence
56. Wind-up and central sensitization are not equivalent
57. Tinnitus and hyperacusis
58. A comparative study of the changes in receptive-field properties of multireceptive and nociceptive rat dorsal horn neurons following noxious mechanical stimulation
59. Central tinnitus and lateral inhibition: An auditory brainstem model
60. Reorganization of auditory cortex in tinnitus
61. Pathophysiology of tinnitus
62. Microvascular decompression surgery for tinnitis
63. Descending auditory system/cerebellum/tinnitus
64. Benzodiazepine receptor deficiency and tinnitus
65. Psychoacoustic measures of tinnitus
66. Are there any safe and effective drugs available to treat my tinnitus?
67. Reviews of pharmacological treatment of tinnitus
68. Therapeutic blind alleys
69. Intratympanic and round-window drug therapy: Effect on cochlear tinnitus
70. Glutamate antagonists, steroids, and antioxidants as therapeutic options for hear loss and tinnitus and the use of an inner ear drug delivery system
71. Treatment of cochlear tinnitus with dexamethasone infusion into the tympanic cavity
72. Quantification of solute entry into the cochlear perilymph through the round window membrane
73. Receptor pharmacological models for inner ear therapies with emphasis on glutamate receptors: A survey
74. Chemical synaptic transmission in the cochlea
75. Uptake and release of d-aspartate, GABA and glycine in guinea pig brainstem auditory nuclei
76. Evidence for glutamatergic projections from the cochlear nucleus to the superior olive and ventral nucleus of the lateral lemniscus
77. Directly gated transmission at central synapses
78. Excitatory amino acids as a final common pathway for neurologic disorders
79. Treatment of central nervous system degenerative disorders
80. Glutamate and aspartate
81. Pathophysiology of the glutamate synapses in the cochlea
82. Implication of non-NMDA and NMDA receptors in cochlear ischemia
83. Neurotransmitters and neuromodulators of the mammalian cochlea
84. Tinnitus treatment with transmitter antagonists
85. Drug treatments for tinnitus at Tulane University School of Medicine
86. Calpain inhibitors as neuroprotective agents in neurodegenerative disorders
87. Protecting the inner ear from acoustic trauma
88. Caroverine in tinnitus treatment
89. Use of masking for tinnitus
90. The treatment of annoying tinnitus with electrical stimulation
91. Phantom auditory perception (tinnitus): Mechanisms of generation and perception